Receipt of R&D Tax Incentive Refund
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Resonance Health Ltd has announced the receipt of a refund from the Australian Taxation Office related to its Research and Development tax incentive for the previous financial year. The refund amount is the net difference between the total R&D tax incentive and the income tax payable by the company. This cash refund will contribute to the company's cash reserves, which will be detailed in the upcoming quarterly report.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Resonance Health
- Half Year Results Presentation
- Half Year Results
- Half Year Report & Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- AGM Presentation
Later from Resonance Health
- Profit Guidance Upgrade
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
- Cessation of Quarterly Reporting
- FY26 Full Year Results Webinar
- Appendix 4E, Full Year Statutory Accounts & Annual Report
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health